PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 8959118

  • 21. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma.
    Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt WR.
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):796-803. PubMed ID: 10329812
    [Abstract] [Full Text] [Related]

  • 22. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R, Rachelefsky G, Harris AG, Chen R.
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [Abstract] [Full Text] [Related]

  • 23. Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate.
    Berend N, Kellett B, Kent N, Sly PD, Collaborative Study Group of the Australian Lung Foundation.
    Respirology; 2001 Sep; 6(3):237-46. PubMed ID: 11555383
    [Abstract] [Full Text] [Related]

  • 24. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.
    Adams N, Lasserson TJ, Cates CJ, Jones PW.
    Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD002310. PubMed ID: 17943772
    [Abstract] [Full Text] [Related]

  • 25. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
    Adams N, Bestall JM, Lasserson TJ, Jones PW.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002310. PubMed ID: 15846637
    [Abstract] [Full Text] [Related]

  • 26. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
    Respir Med; 1999 Dec 18; 93(12):876-84. PubMed ID: 10653049
    [Abstract] [Full Text] [Related]

  • 27. Significant variability in response to inhaled corticosteroids for persistent asthma.
    Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
    J Allergy Clin Immunol; 2002 Mar 18; 109(3):410-8. PubMed ID: 11897984
    [Abstract] [Full Text] [Related]

  • 28. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
    Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.
    J Asthma; 2001 May 18; 38(3):229-37. PubMed ID: 11392363
    [Abstract] [Full Text] [Related]

  • 29. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
    Nathan RA, Nolop KB, Cuss FM, Lorber RR.
    Chest; 1997 Jul 18; 112(1):34-9. PubMed ID: 9228354
    [Abstract] [Full Text] [Related]

  • 30. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
    Dahl R, Lundback B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, Barnacle H.
    Chest; 1993 Nov 18; 104(5):1352-8. PubMed ID: 8222787
    [Abstract] [Full Text] [Related]

  • 31. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL.
    Thorax; 1995 Oct 18; 50(10):1044-50. PubMed ID: 7491551
    [Abstract] [Full Text] [Related]

  • 32. [Effect of fluticasone propionate at half dose of beclomethasone dipropionate divided twice daily and once daily in asthmatics inhaling beclomethasone dipropionate 800 micrograms daily or more].
    Hasegawa T, Tomii K, Kikumoto N, Sakamoto H, Maekawa T, Katayama S, Kamei T, Sakamoto Y, Fujii H, Ishihara K.
    Arerugi; 2001 Apr 18; 50(4):379-84. PubMed ID: 11398334
    [Abstract] [Full Text] [Related]

  • 33. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.
    Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA.
    Eur Respir J; 1999 Jun 18; 13(6):1267-75. PubMed ID: 10445600
    [Abstract] [Full Text] [Related]

  • 34. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma.
    Adams N, Bestall JM, Lasserson TJ, Jones PW.
    Cochrane Database Syst Rev; 2004 Jun 18; (2):CD002310. PubMed ID: 15106173
    [Abstract] [Full Text] [Related]

  • 35. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
    Lasserson TJ, Cates CK, Jones AB, Steele EH, White J.
    Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005309. PubMed ID: 16625634
    [Abstract] [Full Text] [Related]

  • 36. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H, Yamase H.
    Arerugi; 2003 Jan 19; 52(1):31-8. PubMed ID: 12598720
    [Abstract] [Full Text] [Related]

  • 37. Fluticasone versus beclomethasone or budesonide for chronic asthma.
    Adams N, Bestall JM, Jones PW.
    Cochrane Database Syst Rev; 2002 Jan 19; (1):CD002310. PubMed ID: 11869636
    [Abstract] [Full Text] [Related]

  • 38. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD, Moore A, Mersmann S, Dissanayake S.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct 19; 30(5):373-380. PubMed ID: 28510491
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
    Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
    J Int Med Res; 2007 Oct 19; 35(3):361-73. PubMed ID: 17593865
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM.
    J Allergy Clin Immunol; 1999 Feb 19; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.